Aragen's new cell line development and early manufacturing platform, CHOMax, can cut timelines to approximately 10 months.

Johnson & Johnson's agreement with the Trump administration enables patients to access drugs at a comparable price to other ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Sharp Sterile Manufacturing is investing $28 million to expand its site in Lee, Massachusetts, which offers a range of ...

AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...

Novotech, a full-service biotech clinical research organization (CRO), has appointed Dr. Anand Tharmaratnam as its new Chief ...

Eli Lilly and Company has entered a definitive agreement to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

Rentschler Biopharma, a global CDMO for biopharmaceuticals, and VarmX, a biotech company developing direct oral ...

Magali Haas, MD, PhD, founded Cohen Veterans Bioscience and worked at Johnson & Johnson before becoming Psilera's new Chief ...

Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...